Pharmacokinetics of IAsp Following CSII in Patients With T1DM
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare SSPIAsp during CSII giving one bolus per
hour compared with multiple boluses per hour.
The secondary objective is to compare SSPIAsp during continuous subcutaneous insulin infusion
(CSII) versus continuous intravenous insulin infusion (CIII).